MTRY

Monterey Bio Acquisition Corporation [MTRY] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

MTRY Stock Summary

In the News

MTRY Financial details

Company Rating
Sell
Market Cap
48.3M
Income
-1.03M
Revenue
0
Book val./share
3.97
Cash/share
0.11
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-31.05
Forward P/E
-
PEG
-3.72
P/S
-
P/B
1.65
P/C
101.27
P/FCF
-49.23
Quick Ratio
0.18
Current Ratio
0.18
Debt / Equity
0.1
LT Debt / Equity
-
-
-
EPS (TTM)
-0.2
EPS next Y
-
EPS next Q
1.58
EPS this Y
300%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-0.32%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
34.58%
Inst Trans
0.74%
ROA
-5%
ROE
-5%
ROC
-0.1%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
4.34M
Shs Float
1.1M
-
-
-
-
Target Price
-
52W Range
10.21-12.0
52W High
-7.17%
52W Low
+11.4%
RSI
42
Rel Volume
1.23
Avg Volume
3.45K
Volume
4.24K
Perf Week
0%
Perf Month
-1.07%
Perf Quarter
-
Perf Half Y
-1.33%
-
-
-
-
Beta
-
-
-
Volatility
0%, 0.07%
Prev Close
0%
Price
11.14
Change
0%

MTRY Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K
Revenue per share
000
Net income per share
0-0.11-0.44
Operating cash flow per share
0-0.18-0.35
Free cash flow per share
0-0.18-0.35
Cash per share
100.17.37
Book value per share
9.621.856.87
Tangible book value per share
9.621.856.87
Share holders equity per share
9.621.856.87
Interest debt per share
00-0.31
Market cap
24.75K52.78M30.19M
Enterprise value
-25052.26M30.04M
P/E ratio
-10.31K-90.86-23.7
Price to sales ratio
000
POCF ratio
0-56.16-30.07
PFCF ratio
0-56.16-30.07
P/B Ratio
1.030.451.53
PTB ratio
1.030.451.53
EV to sales
000
Enterprise value over EBITDA
0-113.58-14.73
EV to operating cash flow
0-55.62-29.92
EV to free cash flow
0-55.62-29.92
Earnings yield
0-0.01-0.04
Free cash flow yield
0-0.02-0.03
Debt to equity
000
Debt to assets
000
Net debt to EBITDA
01.110.07
Current ratio
253.250.23
Interest coverage
002.31
Income quality
01.610.79
Dividend Yield
000
Payout ratio
000
Sales general and administrative to revenue
000
Research and developement to revenue
000
Intangibles to total assets
000
Capex to operating cash flow
000
Capex to revenue
000
Capex to depreciation
000
Stock based compensation to revenue
000
Graham number
0.467.38.27
ROIC
00-0.11
Return on tangible assets
00-0.06
Graham Net
9.60.056.78
Working capital
24K643.92K-1.29M
Tangible asset value
24K117.07M19.74M
Net current asset value
24K643.92K-1.29M
Invested capital
000
Average receivables
015K15K
Average payables
000
Average inventory
000
Days sales outstanding
000
Days payables outstanding
000
Days of inventory on hand
000
Receivables turnover
000
Payables turnover
000
Inventory turnover
000
ROE
00-0.06
Capex per share
000

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric History 2022-06-302022-09-302022-12-312023-03-31 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-0.01-0.03-0.11-0.03-0.03
Operating cash flow per share
-0.01-0.01-0.13-0.03-0.07
Free cash flow per share
-0.01-0.01-0.13-0.03-0.07
Cash per share
8.088.230.054.440.11
Book value per share
8.111.416.8743.97
Tangible book value per share
8.111.416.8743.97
Share holders equity per share
8.111.416.8743.97
Interest debt per share
-0.01-0.04-0.070.190.39
Market cap
144.04M143.27M30.19M52.27M53.45M
Enterprise value
144.03M142.73M30.04M53.2M54.83M
P/E ratio
-190.66-85.18-24.57-85.83-88.2
Price to sales ratio
00000
POCF ratio
-853.66-1.18K-77.99-394.42-157.08
PFCF ratio
-853.66-1.18K-77.99-394.42-157.08
P/B Ratio
1.247.151.532.672.75
PTB ratio
1.247.151.532.672.75
EV to sales
00000
Enterprise value over EBITDA
-420.13-165.22-64.86-156.88-149.96
EV to operating cash flow
-853.63-1.18K-77.62-401.4-161.14
EV to free cash flow
-853.63-1.18K-77.62-401.4-161.14
Earnings yield
00-0.0100
Free cash flow yield
00-0.010-0.01
Debt to equity
0000.060.1
Debt to assets
0000.050.09
Net debt to EBITDA
0.010.630.31-2.73-3.77
Current ratio
1.380.010.230.170.18
Interest coverage
2.191.652.461.510
Income quality
0.890.291.260.872.25
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
1.550.974.061.671.66
ROIC
0-0.05-0.03-0.02-0.02
Return on tangible assets
00-0.01-0.01-0.01
Graham Net
8.061.36-0.533.97-0.5
Working capital
110.71K-96.5M-1.29M-1.9M-2.43M
Tangible asset value
116.52M20.05M19.74M19.59M19.44M
Net current asset value
110.71K-96.5M-1.29M-1.9M-2.43M
Invested capital
0000.060.1
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
0-0.02-0.02-0.01-0.01
Capex per share
00000

MTRY Frequently Asked Questions

What is Monterey Bio Acquisition Corporation stock symbol ?

Monterey Bio Acquisition Corporation is a US stock , located in New york of Ny and trading under the symbol MTRY

What is Monterey Bio Acquisition Corporation stock quote today ?

Monterey Bio Acquisition Corporation stock price is $11.14 today.

Is Monterey Bio Acquisition Corporation stock public?

Yes, Monterey Bio Acquisition Corporation is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Check Those
Similar Market Cap